サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1179904

聴診器の世界市場-2023-2030

Global Stethoscope Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 200 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
聴診器の世界市場-2023-2030
出版日: 2023年01月05日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

聴診器の世界市場規模は、予測期間（2023年～2030年）にCAGR5.6％で成長するとされています。

聴診器は、心臓、肺、お椀などの体内音を増幅することができます。すべての内臓音には「標準」周波数帯があり、医師は患者の検診の際にそれを聞いています。

市場力学

老年人口の増加と関連する慢性疾患は、聴診器の世界市場の成長を促進します。

世界の老年人口の増加と加齢に伴う慢性疾患は、市場の成長を促進させるでしょう。

National Council on Aging, Inc.によると、65歳以上の成人の約80%が少なくとも1つの疾患を抱えており、68%が2つ以上の疾患を持っています。高齢者に多い疾患としては、慢性閉塞性肺疾患（COPD）、心不全、慢性腎臓病（CKD）、虚血性心疾患（または冠動脈疾患）、高血圧症（高血圧）などが挙げられます。老年人口の増加と関連する慢性疾患は、予測期間中に聴診器の世界市場の成長を促進します。例えば、米国経済社会局によると、2020年の65歳以上の人口は約7億2700万人で、2050年には15億人に達すると推定されています。世界の65歳以上人口のシェアは、2050年までに16％になると予想されています。NIHによると、2030年には85歳以上の人口が急増します。

さらに、米国肺協会によると、2020年には成人の5.0%にあたる1250万人がCOPD（慢性閉塞性肺疾患、慢性気管支炎、肺気腫）の診断を受けていると報告されています。若い年齢層と比較して、65歳以上でその割合が高くなっています。米国心臓協会（American Heart Association, Inc.）の2022年心臓病・脳卒中統計更新ファクトシートによると、2020年の世界の死因はCVDが約1,905万人を占めるとされています。したがって、上記のデータは、老年人口と関連する慢性疾患の増加が、予測期間中に世界の聴診器市場の成長を促進することを示しています。

高いコストと熟練した医療従事者の不足が、世界の聴診器市場の成長を阻害します。

しかし、いくつかの変種の高コストと熟練したヘルスケア専門家の不足は、市場の抑制要因となるでしょう。最先端技術の変種の中には高価なものもあり、一部のヘルスケア専門家はそれを購入することができません。同様に、専門的なヘルスケアプロバイダーの不足とハイエンド製品への不十分な理解が、業界の成長を妨げると思われます。

COVID-19の影響分析

COVID-19の流行により、ヘルスケア支援の必要性が高まり、COVID-19は呼吸器系疾患であるため、治療状況における肺と心臓への注目の拡大が不可欠です。このような特殊な状況下で、既存の治療法では困難なさまざまな結果をもたらすため、ここでもテクノロジーを駆使したヘルスケアの答えが追求されているのです。ワイヤレス聴診器は、世界の技術ブームの中で、この珍しい病気を最小限の感染リスクで治療するために不可欠なものです。したがって、ヘルスケア支援に対するニーズの高まりと、聴診器におけるパンデミック主導のイノベーションが、世界市場にプラスの影響を与えています。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場影響要因
    • 促進要因
      • 老年人口の増加
      • 技術革新と開発
    • 抑制要因
      • 高コストとヘルスケア専門家の不足
    • ビジネスチャンス
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 規制分析

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、または将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的取り組み
  • まとめ

第7章 製品タイプ別

  • 電子式
  • アコースティック

第8章 デザイン別

  • シングルヘッド
  • ダブルヘッド
  • トリプルヘッド

第9章 エンドユーザー別

  • 病院・クリニック
  • ヘルスケア施設
  • 外来手術センター（ASC）
  • 在宅医療施設
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第11章 競合情勢

  • 競合シナリオ
  • 製品ベンチマーク
  • 主な展開と戦略

第12章 企業プロファイル

  • 3M
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Welch Allyn
  • American Diagnostic Corporation
  • EKuore
  • Dongjin Medical Co. Ltd
  • Cardionics
  • Eko Devices
  • Medline Industries Inc.
  • Smiths Medical
  • GF Health Products Inc.

第13章 DataM

目次
Product Code: DMMD1261

Market Overview

The global stethoscope market size was valued at US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 5.6% during the forecast period (2023-2030).

The stethoscope allows the amplification of internal body sounds from the heart, lungs, and bowls. Every internal organ sound has a "standard" frequency range that doctors listen to during patient checkups.

Market Dynamics

The rising geriatric population and related chronic diseases promote the global stethoscope market growth.

The growing geriatric population and age-related chronic diseases worldwide will fuel the market growth.

According to the National Council on Aging, Inc., around 80% of adults 65 and older have at least one condition, while 68% have two or more. A few of the most common conditions among older adults are Chronic obstructive pulmonary disease (COPD), Heart failure, chronic kidney disease (CKD), Ischemic heart disease (or coronary heart disease), Hypertension (high blood pressure), and others. The growing geriatric population and related chronic cases fuel the global stethoscope market growth during the forecast period. For instance, according to the United States Department of Economics and Social Affairs, about 727 million people aged 65 and over in 2020 are estimated to reach 1.5 billion by 2050. share of the population 65 and above globally is expected to be 16% by 2050. According to NIH, by 2030, the population of people aged 85 and over will rise rapidly.

Moreover, according to the American Lung Association, in 2020, 12.5 million people, or 5.0% of adults, reported a diagnosis of COPD (chronic obstructive pulmonary disease, chronic bronchitis, or emphysema. Rates were higher among those 65 and older compared to younger age groups. According to the 2022 heart disease and Stroke Statistics Update Fact Sheet from American Heart Association, Inc., CVD accounted for approximately 19.05 million global deaths in 2020. Thus, the above data indicate that the growing geriatric population and related chronic diseases will drive the growth of the worldwide stethoscope market during the forecasted period.

The high cost and dearth of skilled healthcare professionals will hamper the global Stethoscope market growth.

However, the high cost of some variants and the dearth of skilled healthcare professionals will be a market-restraining aspect. Some of the cutting-edge technology variants are costly, and a few healthcare professionals cannot afford them. Likewise, the shortage of professional healthcare providers and inadequate understanding of high-end products will hinder the industry's growth.

COVID-19 Impact Analysis

Because of the COVID-19 pandemic, the need for healthcare assistance is raised and since COVID-19 is a respiratory disease, expanding attention to the lungs and heart in therapeutic circumstances is vital. Again, tech-enabled healthcare answers are being pursued when this unique situation leads to different outcomes that are challenging to treat with existent practices. Wireless stethoscopes are essential to the worldwide technology boom for treating this unusual disease with minimal risk of transmission. Therefore, the increased need for healthcare assistance and pandemic-driven innovations in stethoscopes has positively impacted the global market.

Segment Analysis

The electronic stethoscope is predicted to grow at the fastest CAGR during the forecast period (2022-2029)

An electronic stethoscope electronically amplifies body sounds. Since the sound signals are transmitted electronically, they can be wireless, provide noise reduction and interfaced with computers, thereby can be further investigated and stored for future usefulness. Electronic stethoscopes are anticipated to boost at a high CAGR during the projection years owing to the new product developments and introductions into the market. According to For instance, in August 2021, Eko Devices, Inc. launched its DUO ECG + Digital Stethoscope. This two-in-one electronic stethoscope tracks electrical activity and can be integrated with hospital electronic health records. Similarly, in 2020, Thinklabs One introduced Safe Distance AuscultationTM, a technologically sophisticated digital stethoscope that allows healthcare experts to be safe during COVID-19. Likewise, in April 2020, Polish telemedicine innovations company StethoMe launched its artificial intelligence wireless stethoscope after its current collaborations with MaQuestionMedicale and HomeDoctor, prominent European telemedicine providers.

Similarly, in April 2022, the Centre for Development of Advanced Computing (C-DAC) based in Mohali designed a wireless electronic stethoscope that allows doctors from remote locations to diagnose patients' heartbeats. Again, in April 2022, Israeli startup Sanolla Ltd. received the United States Food and Drug Administration 510(k) clearance for its smart-infrasound stethoscope Vox. Thus, the abovementioned data indicates that the increasing product developments and introductions contribute to the growth of the electronic stethoscope segment in the forecasted period.

Geographical Analysis

The North American region dominates the global Stethoscope market.

The initiatives by various government and non-government organizations to raise awareness & understanding of cardiac and pulmonary diseases are fueling the North American stethoscope market growth at a high CAGR. For example, a national initiative called "Million Hearts 2022" is being followed to avert 1 million heart attacks within five years. It is a joint endeavor of the Centers for Disease Control and Prevention and the Centers for Medicare & Medicaid Services. Likewise, the National Heart, Lung, and Blood Institute has started a national campaign: Learn More, Breathe Better, to expand awareness & understanding of COPD and its risk factors. Additionally, this campaign supports earlier detection and treatment in slowing the disease and enhancing the quality of life.

Furthermore, different market developments in this region also contribute to the North American stethoscope market growth. For instance, in November 2021, eMurmur, a global healthcare technology partner, released the world's first open software platform for advanced digital auscultation (stethoscope technology), presently available in the United States. Similarly, in April 2022, Sanolla introduced the AI-ready VoqX infrasound stethoscope for clinical use in the United States. Again, in June 2021, HD Medical made its flagship product, HD Steth, available online through Stethoscope.com, one of the leading online stethoscope and medical product distributors in the United States.

Additionally, the growing number of hospital visits in North America ensures the hold of North America over the global stethoscope market. According to the CDC, about 83.4% of adults visited a healthcare professional in the U.S. in 2020. The number of visits in the U.S. was 860.4 million, and the percentage of visits made to primary care physicians was 51.2%. Therefore, the above data indicate that North America will dominate the global stethoscope market throughout the forecast period.

Competitive Landscape

The Stethoscope market is moderately competitive due to the presence of key local and global players. Some key players are Welch Allyn, 3M, American Diagnostic Corporation, EKuore, Dongjin Medical Co. Ltd, Cardionics, Eko Devices, Medline Industries Inc., Smiths Medical and GF Health Products Inc. The key players keep the majority of their market share to themselves through innovations, product launches, collaborations, acquisitions, and alliances. For instance, in October 2020, 3M and Eko formed a partnership to combine 3M's Littmann stethoscope with Eko's digital innovations.

3M

Overview:

3M is a leading manufacturer all over the world. It has a global presence and is headquartered in Saint Paul, Minnesota, the United States, which was founded on June 13, 1902. 3M deals with 60,000 various products under many brands; the product categories are adhesives, abrasives, laminates, passive fire protection, personal protective equipment, window films, paint protection films, dental and orthodontic products, electrical and electronic connecting and insulating materials, medical products, car-care products, electronic circuits, healthcare software and optical films.

Product Portfolio:

The 3M product portfolio of Stethoscope has 3M Littmann CORE Digital Stethoscope: The 3M Littmann CORE Digital Stethoscope delivers up to 40x amplification (at peak frequency versus analog mode), active noise cancellation, in-app sound wave visualization and other powerful features developed to give a clearer picture of patient health.

The global stethoscope market report would provide access to approximately 40 + market data tables, 45 + figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Increasing Geriatric Population
      • 4.1.1.2. Innovations And Developments
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost and Lack of Healthcare Professionals
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Electronic
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Acoustic

8. By Design

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 8.1.2. Market Attractiveness Index, By Design
  • 8.2. Single Head
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Double Head
  • 8.4. Triple Head

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals And Clinics
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Healthcare Institutions
  • 9.4. Ambulatory surgical centers (ASCs)
  • 9.5. Home care Settings
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Product Benchmarking
  • 11.3. Key Developments and Strategies

12. Company Profiles

  • 12.1. 3M
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Welch Allyn
  • 12.3. American Diagnostic Corporation
  • 12.4. EKuore
  • 12.5. Dongjin Medical Co. Ltd
  • 12.6. Cardionics
  • 12.7. Eko Devices
  • 12.8. Medline Industries Inc.
  • 12.9. Smiths Medical
  • 12.10. GF Health Products Inc.

LIST NOT EXHAUSTIVE

13. DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us